Weu Wang

Taipei Medical University Hospital

Papers

3

Total Citations

92

H-Index

2

About

Weu Wang is a leading researcher in colorectal surgery, specializing in the comparative effectiveness of robotic-assisted and laparoscopic techniques for cancer treatment. His work directly addresses the clinical controversy surrounding robotic surgery, providing critical evidence on outcomes and complication rates. Wang’s most-cited paper, a 2019 systematic review and meta-analysis of randomized controlled trials (61 citations), rigorously evaluates the benefits of robotic-assisted mesorectal excision for rectal cancer, clarifying its role in reducing conversion to open laparotomy. He further advances the field by pioneering comparisons of robotic reduced-port surgery versus conventional laparoscopic approaches for left-sided colorectal cancer (2022, 29 citations), demonstrating how reduced-port techniques can overcome limitations of single-incision surgery while preserving its advantages. Wang’s research has significantly shaped surgical decision-making, offering data-driven insights that help surgeons optimize patient outcomes. His meticulous meta-analyses and comparative studies have earned him recognition as a key voice in minimally invasive colorectal oncology, with his findings widely cited by clinicians and researchers seeking to refine surgical protocols and improve recovery for cancer patients.

Research Focus

Key Achievements

2
H-Index
3
Papers
92
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Effects of laparoscopic vs robotic-assisted mesorectal excision for rectal cancer: An update systematic review and meta-analysis of randomized controlled trials
61 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Taipei Medical University Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago